CUA and Pfizer Canada Launch New Incontinence Fellowship

CUA and Pfizer Canada Launch New Incontinence Fellowship 
Incontinence Fellowship application deadline is April 1, 2013 
KIRKLAND, QUEBEC -- (Marketwire) -- 02/06/13 -- The Canadian
Urological Association (CUA) and Pfizer Canada have announced a new
fellowship program offering support and funding for Canadian
urological researchers. The fellowship is focused on advancing
urological research and improving care for patients with
incontinence. The partnership will take place over two years,
awarding $120,000 per year. The first wave of the fellowship program
will take place in 2013-2014.  
"With the growing burden of urological disorders in Canada, there is
an immediate need to foster the training of our new clinicians in
order to lead the charge in scientific discovery and innovation in
urology, and specifically in the field of incontinence," says Dr.
Robert Siemens, Chair of the Administrative Council of the Canadian
Urological Association Scholarship Foundation (CUASF). The first two
grants will be awarded at the Annual Meeting of the CUA in June 2013. 
Fellowship Funds 

--  For a 12-month period, 2 recipients will each receive a grant of $60,000
    (CDN) (total $120,000) 
--  A second year with two new fellowships will take place in 2014-2015
    (total $120,000) 

Eligible Applicants 

--  Must have completed Royal College of Physicians and Surgeons of Canada
    (FRCSC) requirements in Urology 
--  Canadian residents 
--  M.D. trained individuals 
--  The main applicant must be a Canadian Urological Association (CUA)
    member (active or candidate) 
--  Agrees to provide a progress report, including any publication/congress
    plan, to the CUASF for dissemination 

For more information on how to apply, eligible research proposals,
review criteria, notification dates and submission process please
Applications must be received by April 1, 2013.  
About Canadian Urological Association 
The Canadian Urological Association represents and provides a voice
for all Canadian urologists and fosters dedications of all members of
the profession toward ensuring the highest possible standard of
urologic care of Canadians. 
About Pfizer Canada 
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., one of
the world's leading biopharmaceutical companies. The company is one
of the largest contributors to health research in Canada. Every day,
Pfizer Canada employees work to advance wellness, prevention,
treatments and cures that challenge the most feared diseases of our
time. Our commitment is reflected in everything Pfizer does, from our
disease awareness initiatives to our community partnerships, to our
belief that it takes more than medication to be truly healthy. To
learn more about Pfizer's More than Medication philosophy and
programs, visit To learn more about Pfizer
Canada, visit 
Strategic Objectives
David Weinstein
416-366-7735 or Toll free: 1-866-366-7733 
Strategic Objectives
Nadine Rashad
416-366-7735 or Toll free: 1-866-366-7733 
Strategic Objectives
Debra Quinn
416-366-7735 or Toll free: 1-866-366-7733
Canadian Urological Association
Ms. Raffaella Leroux
Press spacebar to pause and continue. Press esc to stop.